AU2020335909A1 - System for regulating gene expression - Google Patents

System for regulating gene expression Download PDF

Info

Publication number
AU2020335909A1
AU2020335909A1 AU2020335909A AU2020335909A AU2020335909A1 AU 2020335909 A1 AU2020335909 A1 AU 2020335909A1 AU 2020335909 A AU2020335909 A AU 2020335909A AU 2020335909 A AU2020335909 A AU 2020335909A AU 2020335909 A1 AU2020335909 A1 AU 2020335909A1
Authority
AU
Australia
Prior art keywords
polya
seq
aptamer
nucleic acid
vector
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2020335909A
Other languages
English (en)
Inventor
Jocelyn Duen-Ya JEA
Liming LUO
Laising Yen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baylor College of Medicine
Original Assignee
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baylor College of Medicine filed Critical Baylor College of Medicine
Publication of AU2020335909A1 publication Critical patent/AU2020335909A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2020335909A 2019-08-30 2020-08-28 System for regulating gene expression Pending AU2020335909A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962894611P 2019-08-30 2019-08-30
US62/894,611 2019-08-30
US201962904635P 2019-09-23 2019-09-23
US62/904,635 2019-09-23
US202063043504P 2020-06-24 2020-06-24
US63/043,504 2020-06-24
PCT/US2020/048561 WO2021041924A2 (en) 2019-08-30 2020-08-28 System for regulating gene expression

Publications (1)

Publication Number Publication Date
AU2020335909A1 true AU2020335909A1 (en) 2022-04-14

Family

ID=74683442

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020335909A Pending AU2020335909A1 (en) 2019-08-30 2020-08-28 System for regulating gene expression

Country Status (11)

Country Link
US (1) US20220290147A1 (https=)
EP (1) EP4022065A4 (https=)
JP (2) JP7737152B2 (https=)
KR (1) KR20220049619A (https=)
CN (1) CN115279902A (https=)
AU (1) AU2020335909A1 (https=)
BR (1) BR112022003512A2 (https=)
CA (1) CA3152513A1 (https=)
IL (1) IL290944A (https=)
MX (1) MX2022002390A (https=)
WO (1) WO2021041924A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102904879B1 (ko) 2015-11-12 2025-12-30 베이롤 칼리지 오브 메드신 폴리아데닐화의 압타머 매개된 조정을 통한 포유류 유전자 발현의 외인성 제어
AU2022327174A1 (en) 2021-08-11 2024-02-15 Sana Biotechnology, Inc. Inducible systems for altering gene expression in hypoimmunogenic cells

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003295600A1 (en) * 2002-11-14 2004-06-15 Dharmacon, Inc. Functional and hyperfunctional sirna
CA2559280A1 (en) 2004-03-15 2005-09-29 Biogen Idec Ma Inc. Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
WO2005106035A2 (en) * 2004-04-09 2005-11-10 Cornell Research Foundation, Inc. Modular design and construction of nucleic acid molecules, aptamer-derived nucleic acid constructs, rna scaffolds, their expression, and methods of use
WO2005116204A1 (ja) * 2004-05-11 2005-12-08 Rnai Co., Ltd. Ｒｎａ干渉を生じさせるポリヌクレオチド、および、これを用いた遺伝子発現抑制方法
US7825229B2 (en) * 2005-03-25 2010-11-02 Rosetta Genomics Ltd. Lung cancer-related nucleic acids
US8178503B2 (en) * 2006-03-03 2012-05-15 International Business Machines Corporation Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
US20150284738A1 (en) * 2006-12-29 2015-10-08 Rodina Holding S.A. Artificial dna sequence with optimized leader function in 5' (5'-utr) for the improved expression of heterologous proteins in plants
CN103108952A (zh) * 2010-09-01 2013-05-15 日本电气株式会社 检测目标物质的方法以及用于所述方法中的适体组、传感器和装置
EP2622084A1 (en) * 2010-10-01 2013-08-07 R1 B3 Holding B.V. Regulation of translation of expressed genes
WO2013119371A2 (en) * 2012-02-10 2013-08-15 The Board Of Trustees Of The Leland Stanford Junior University Mini-intronic plasmid vectors
US20150141320A1 (en) * 2012-05-16 2015-05-21 Rana Therapeutics, Inc. Compositions and methods for modulating gene expression
US9567581B2 (en) * 2012-08-07 2017-02-14 The General Hospital Corporation Selective reactivation of genes on the inactive X chromosome
KR102699584B1 (ko) 2015-02-02 2024-08-28 메이라지티엑스 유케이 Ii 리미티드 대안적 스플라이싱의 압타머 매개 조절에 의한 유전자 발현 제어
EP3268481B1 (en) * 2015-03-11 2020-05-27 The United States of America, as represented by The Secretary, Department of Health and Human Services Rpgr vectors for treating x-linked retinitis pigmentosa
KR102904879B1 (ko) * 2015-11-12 2025-12-30 베이롤 칼리지 오브 메드신 폴리아데닐화의 압타머 매개된 조정을 통한 포유류 유전자 발현의 외인성 제어

Also Published As

Publication number Publication date
US20220290147A1 (en) 2022-09-15
IL290944A (en) 2022-04-01
WO2021041924A2 (en) 2021-03-04
MX2022002390A (es) 2022-05-13
JP2025118711A (ja) 2025-08-13
JP2022546408A (ja) 2022-11-04
CN115279902A (zh) 2022-11-01
BR112022003512A2 (pt) 2022-05-17
KR20220049619A (ko) 2022-04-21
EP4022065A2 (en) 2022-07-06
JP7737152B2 (ja) 2025-09-10
WO2021041924A3 (en) 2021-04-08
EP4022065A4 (en) 2024-02-14
CA3152513A1 (en) 2021-03-04

Similar Documents

Publication Publication Date Title
US12415994B2 (en) Synthetic miniature Crispr-Cas (CasMINI) system for eukaryotic genome engineering
TWI839337B (zh) 用於基因組編輯之多核苷酸、組合物及方法
AU2018338787C1 (en) Compositions and methods for TTR gene editing and treating ATTR amyloidosis
JP7550057B2 (ja) ドナーポリヌクレオチドの挿入によるゲノム編集のための組成物および方法
CN106572974A (zh) 用于将分子有效递送到细胞的具有脂质聚集体的组合物和方法
JP2002525066A (ja) 核酸の特異的な細胞の局在化のための転写法
US20230383275A1 (en) Sgrna targeting aqp1 rna, and vector and use thereof
JP2025118711A (ja) 遺伝子発現を調節するためのシステム
CN116783295A (zh) 指导rna的新型设计及其用途
RU2825581C1 (ru) Система регуляции экспрессии генов
WO2024040202A1 (en) Fusion proteins and uses thereof for precision editing
JP4709971B2 (ja) 細胞内へ核酸を導入する為の新規な分子並びに細胞内へ導入する核酸および細胞内へ核酸を導入する為の新規な方法
WO2025184186A1 (en) Excision of exon 53 for treatment of duchenne muscular dystrophy
JP2025514304A (ja) 遺伝子治療法のための組織特異的遺伝子外セーフハーバーの同定
KR20250158036A (ko) 리보자임-매개 rna 조립 및 발현
WO2025016408A1 (zh) 一种可用于筛选针对rna重复序列药物的报告系统
WO2026045988A1 (zh) 反向引导编辑系统
EP4490291A1 (en) Precise excisions of portions of exons for treatment of duchenne muscular dystrophy
WO2025072763A2 (en) Compositions and methods for precision editing with cas dimers
EA048813B1 (ru) Композиции и способы редактирования гена ttr и лечения транстиретинового амилоидоза (attr)
EA053115B1 (ru) Полинуклеотиды, композиции и способы редактирования генома
HK40032638B (zh) 用於基因组编辑的多核苷酸、组合物及方法
HK40005508A (en) Lipid nanoparticle formulations for crispr/cas components